Frédéric Desmoulins

Efficacy and safety of belimumab in primary Sjögren’s syndrome: results of the BELISS open-label phase II study

Xavier Mariette, Raphaèle Séror, Luca Quartuccio et al. · Annals of the Rheumatic Diseases · 2013 · 320 citations

Life Sciences, Immunology, Internal Medicine +17

Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts

Yann Nguyen, Gaëtane Nocturne, Julien Henry et al. · The Lancet Rheumatology · 2024 · 74 citations · Full text

Medicine, Immunology, Internal Medicine +12

Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.

Carine Salliot, Jacques‐Eric Gottenberg, Djaouïda Bengoufa et al. · PubMed · 2007 · 61 citations

Life Sciences, Immunology, Pathology +17

Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients With Primary Sjögren's Syndrome

A. E. F. El Tomi, Rakiba Belkhir, Gaëtane Nocturne et al. · Arthritis & Rheumatology · 2015 · 54 citations

Medicine, Clinical Sciences, Internal Medicine +17

Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren’s syndrome: results of the BELISS study

Raphaèle Séror, Gaëtane Nocturne, Thierry Lazure et al. · Arthritis Research & Therapy · 2015 · 50 citations · Full text

Life Sciences, Immunology, Autoimmunity +13